How does selenium status relate to mortality?
Higher biomarker levels of selenium status correlate significantly with lower mortality rates. This is the conclusion of a 2025 meta-analysis of 20 cohort studies. Importantly, the central finding in the meta-analysis was a consistent inverse association between selenium status and mortality [Cui, Schomburg et al 2025].

Basically, one standard deviation increase in selenium status corresponded to the following reduction in mortality:
- 13% lower all-cause mortality
- 11% lower cardiovascular mortality
- 15% lower cancer mortality
Moreover, Cui et al found low serum Selenoprotein P (SELENOP) concentrations associated with an increased risk of stroke in subjects free of cardiovascular disease and with increased risk of cardiovascular mortality among heart disease patients. The association of SELENOP concentrations with cardiovascular disease incidence was restricted to patients with hypertension or diabetes [Cui 2025].








